Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
- Update frequency
- every 7 days
- Average duration
- 49 minutes
- Episodes
- 270
- Years Active
- 2020 - 2025
Academia + Industry with BridgeBio's Dr. Michael Henderson
We love to hear from our listeners. Send us a message.
BridgeBio has a whopping 18+ pre-clinical to clinical-stage candidates in its pipeline representing an impressive array of modalities and targe…
GSK's Michael Mehler On The Cell & Gene Talent Crunch
We love to hear from our listeners. Send us a message.
Michael Mehler honed his cell therapy chops at Adaptimmune before joining GSK as Senior Clinical Development Manager, Cell Therapy Oncology in 2…
RNA-Engineered Cell Therapy with Cartesian's Dr. Murat Kalayoglu
We love to hear from our listeners. Send us a message.
Cartesian President & CEO Murat Kalayoglu, M.D., Ph.D. has led three of his company's six autoimmune, oncology, and respiratory candidates thro…
Real-Time Clinical Analysis with Glympse Bio's Dr. Caroline Loew
We love to hear from our listeners. Send us a message.
On this episode of the Business of Biotech, we're going deep with Glympse Bio President & CEO Dr. Caroline Loew to explore the possibilities and…
AAV & Lentivirus Gene Therapies with Sio Gene Therapeutics' Dr. Pavan Cheruvu
We love to hear from our listeners. Send us a message.
Fresh on the heels of a significant data readout on its AXO-AAV-GM1 candidate at the recent ASGCT meeting, Sio Gene Therapies CEO Pavan Cheruvu,…
Med Device Meets Biopharma with OncoSec's Dan O'Connor, J.D.
We love to hear from our listeners. Send us a message.
OncoSec CEO & Director Dan O'Connor, J.D. joins the Business of Biotech to discuss his company's development of proprietary application and inje…
Drug Development: From Bench To Bedside With Allan Shaw
We love to hear from our listeners. Send us a message.
CFO to the biopharma stars and frequent Business of Biotech guest Allan Shaw joins us for a candid discussion on the keys to efficiency as you m…
Digital Transformation In Cell Therapy with Organicell Drs. Mari Mitrani & Michael Bellio
We love to hear from our listeners. Send us a message.
Drs. Mari Mitrani, CSO and Michael Bellio, Laboratory Director are young pioneers in the study of the therapeutic potential of exosomes. Their r…
Biopharma Regulatory Requirements with bluebird bio's Scott Cleve
We love to hear from our listeners. Send us a message.
Scott Cleve brings an entire career dedicated to the mastery of global biopharma regulatory standards to his role as Vice President of Regulator…
Filling A Vaccine Void with Cue Biopharma's Dan Passeri, J.D.
We love to hear from our listeners. Send us a message.
CUE Biopharma CEO Dan Passeri, J.D. joins us for a discussion on the development of the company's Immuno-STAT platform for the selective target…
Supercharging An ADC Program With SOTIO CEO Dr. Radek Špíšek
We love to hear from our listeners. Send us a message.
SOTIO isn't your typical single-molecule, single-platform biopharma. Since its inception, the company has supported 14 clinical trials of oncolo…
mAb Manufacturing with Rezolute Bio CEO Nevan Charles Elam, JD
We love to hear from our listeners. Send us a message.
Nevan Charles Elam, JD founded Rezolute Bio ten years ago on the heels of a complex career intersecting law, high tech, and life sciences. On th…
Cell Therapy Platforms With Precigen CEO Dr. Helen Sabzevari
We love to hear from our listeners. Send us a message.
Learn how Precigen is advancing a deep pipeline of immuno-oncology, infectious disease, and autoimmune disorder candidates through the clinic on…
A CFO's Prescription For Biopharma Success With Allan Shaw
We love to hear from our listeners. Send us a message.
Friend of the show and life sciences CFO extraordinaire Allan Shaw joins us for a discussion on the steps to biopharma success from an insider's…
A Biopharma Pivot with Compugen's Dr. Anat Cohen-Dayag
We love to hear from our listeners. Send us a message.
Dr. Anat Cohen-Dayag transformed her company from a computational biology service provider to a clinical-stage biopharma with multiple cancer im…
Preparing For The Clinic With Amolyt Pharma CEO Dr. Thierry Abribat
We love to hear from our listeners. Send us a message.
Amolyt Pharma is developing a therapeutic peptide program targeting rare endocrine and metabolic diseases including hypoparathyroidism and acro…
Pioneering Antiviral Conjugates with Cidara's Dr. Jeff Stein
We love to hear from our listeners. Send us a message.
Cidara Therapeutics President and CEO Dr. Jeff Stein joins the Business of Biotech to discuss his career mission to battle microbial organisms a…
AI & The Human Genome With Dr. Dietrich Stephan
We love to hear from our listeners. Send us a message.
From his Fellowship at the NIH Human Genome Research Institute to his leadership as CEO at NeuBase Therapeutics, Dr. Dietrich Stephan is recogni…
The FDA's Progressive Appeal ft. Allan Shaw
We love to hear from our listeners. Send us a message.
Allan Shaw rejoins the Business of Biotech with candid and deep commentary on the unprecedented pace of biopharma innovation, and how the FDA is…
Celyad CEO Filippo Petti On In-House Allogeneic Cell Therapy Manufacturing
We love to hear from our listeners. Send us a message.
Join Matt Pillar and Erin Harris as we catch up with Celyad Oncology chief Filippo Petti on his company's differentiated approach to the discov…